Nascent Biotech, Inc. (NBIO)

Nascent Biotech Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	0.05	0.37	0.17	0.09	0	0
Cash & Short-Term Investments	0.05	0.37	0.17	0.09	0	0
Cash Growth	399.90%	116.11%	82.37%	6479.37%	-55.41%	-97.55%
Receivables	-	-	-	-	0.75	-
Prepaid Expenses	0.18	0.18	0.08	0.01	-	-
Total Current Assets	0.23	0.55	0.26	0.11	0.75	0
Total Assets	0.23	0.55	0.26	0.11	0.75	0
Accounts Payable	0.68	0.69	0.5	0.78	0.64	0.85
Accrued Expenses	-	-	-	-	-	1.28
Short-Term Debt	0.06	0.12	0.39	-	0.16	0.14
Other Current Liabilities	-	-	0.66	-	0.43	0.6
Total Current Liabilities	0.74	0.81	1.55	0.78	1.22	2.88
Total Liabilities	0.74	0.81	1.55	0.78	1.22	2.88
Common Stock	0.17	0.17	0.13	0.11	0.1	0.04
Additional Paid-In Capital	23.95	23.83	20.19	18.04	17.77	13.92
Retained Earnings	-24.64	-24.26	-21.62	-18.82	-18.35	-16.84
Total Common Equity	-0.51	-0.26	-1.3	-0.67	-0.47	-2.88
Shareholders' Equity	-0.51	-0.26	-1.3	-0.67	-0.47	-2.88
Total Liabilities & Equity	0.23	0.55	0.26	0.11	0.75	0
Total Debt	0.06	0.12	0.39	-	0.16	0.14
Net Cash (Debt)	-0.01	0.25	-0.22	0.09	-0.16	-0.14
Net Cash Per Share	-0.00	0.00	-0.00	0.00	-0.00	-0.00
Filing Date Shares Outstanding	172.2	172.2	141.4	115.01	107.73	48.27
Total Common Shares Outstanding	172.2	170.59	131.76	111.31	104.83	44.89
Working Capital	-0.51	-0.26	-1.3	-0.67	-0.47	-2.88
Book Value Per Share	-0.00	-0.00	-0.01	-0.01	-0.00	-0.06
Tangible Book Value	-0.51	-0.26	-1.3	-0.67	-0.47	-2.88
Tangible Book Value Per Share	-0.00	-0.00	-0.01	-0.01	-0.00	-0.06

Updated Aug 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.